相关实验视频
Updated: Jun 24, 2025

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.3K
在炎症下,埃斯基塔洛普拉姆通过调节血清素输送体表达
Sergio Mena1, Allison Cruikshank2, Janet Best3
1Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK.
Communications biology
|June 8, 2024
概括
选择性血清素再吸收抑制剂 (SSRI) 需要数周时间才能达到稳定状态的血清素水平. 炎症可以减少埃斯基塔洛普拉姆的使用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 是抑郁症的主要治疗方法,但它们的临床疗效和延迟作用仍在争论中.
- 单胺缺乏症假设是SSRI使用的基础,但动物模型难以复制人类疾病的复杂性和剂量.
- 关于SSRI有效性变化和延迟起作用背后的机制存在缺乏共识.
研究的目的:
- 开发一个理论的海马体模型,整合ESCITALOPRAM的药理动力学和药理动力学特性.
- 调查炎症和受体动态对埃斯基塔洛普拉姆效应的影响.
- 阐明慢性埃斯基塔洛普拉姆对大脑血清素的影响背后的机制,并优化抗抑郁药物的发现.
主要方法:
- 开发了 hippocampus 的计算模型,结合了 escitalopram 的药理动力学和药理动力学.
- 在理论小鼠模型中模拟慢性口服埃斯卡托洛普拉姆的使用.
- 嵌入式参数用于血清素载体 (SERT) 内化,炎症和受体动态.
主要成果:
- 模拟表明,慢性埃斯基塔洛普拉姆需要几天到几周才能达到稳定状态的血清激素水平.
- 模型表明,炎症显著降低了埃斯基塔洛普拉姆的化学疗效.
- 确定了ESCITALOPRAM延迟作用和可变疗效的潜在机制.
结论:
- 开发的模型提供了关于慢性埃斯基塔洛普拉姆如何影响大脑的血清激素动态的见解.
- 研究结果强调了最佳剂量和治疗持续时间对抗抑郁药有效性的关键作用.
- 表明炎症是调节SSRI疗效的关键因素,需要进一步调查.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
369
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
369
G-protein Coupled Receptors
118.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.2K

